Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.

UNLABELLED: The identification of associations between interleukin-28B (IL-28B) variants and the spontaneous clearance of hepatitis C virus (HCV) raises the issues of causality and the net contribution of host genetics to the trait. To estimate more precisely the net effect of IL-28B genetic variati...

Full description

Bibliographic Details
Main Authors:	di Iulio, J, Ciuffi, A, Fitzmaurice, K, Kelleher, D, Rotger, M, Fellay, J, Martinez, R, Pulit, S, Furrer, H, Günthard, H, Battegay, M, Bernasconi, E, Schmid, P, Hirschel, B, Barnes, E, Klenerman, P, Telenti, A, Rauch, A
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
by: Rohrbach, J, et al.
Published: (2010)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2008)

Disentangling human tolerance and resistance against HIV.
by: Roland R Regoes, et al.
Published: (2014-09-01)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
by: Fitzmaurice, K, et al.
Published: (2015)

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
by: Wolbers, M, et al.
Published: (2007)

Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.
by: Pejman Mohammadi, et al.
Published: (2014-05-01)

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
by: Glass, T, et al.
Published: (2006)

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
by: Samuel Alizon, et al.
Published: (2010-09-01)

Pharmacogenomics: what is next?
by: Julia edi Iulio, et al.
Published: (2012-01-01)

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
by: Fagard, C, et al.
Published: (2003)

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
by: Oxenius, A, et al.
Published: (2002)

Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak
by: Merani, S, et al.
Published: (2011)

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
by: Elzi Luigia, et al.
Published: (2011-11-01)

Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak.
by: Merani, S, et al.
Published: (2011)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
by: Marie Ballif, et al.
Published: (2009-01-01)

Single-Cell Genomics for Virology
by: Angela Ciuffi, et al.
Published: (2016-05-01)

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
by: Rauch, A, et al.
Published: (2009)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
by: Jiménez-Sousa María A, et al.
Published: (2013-01-01)

Human immunodeficiency virus-specific T lymphocyte cell
by: Oxenius, A, et al.
Published: (2001)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy
by: Gasser, O, et al.
Published: (2013)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
by: Gasser, O, et al.
Published: (2013)

Genetic variations in IL28B and allergic disease in children.
by: Silvana Gaudieri, et al.
Published: (2012-01-01)

HLA FOOTPRINTING REVEALS A NOVEL PROTECTIVE CD8+T CELL RESPONSE IN HEPATITIS C VIRUS INFECTION
by: Fitzmaurice, K, et al.
Published: (2009)

Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.
by: Sayeh Ezzikouri, et al.
Published: (2013-01-01)

PREDICTING CLEARANCE OF ACUTE HCV IN HIV-POSITIVE PATIENTS
by: Thomson, E, et al.
Published: (2009)

Antiretroviral activity of ancestral TRIM5alpha.
by: Goldschmidt, V, et al.
Published: (2008)

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.
by: Buclin, T, et al.
Published: (2011)

An update on hepatitis C virus.
by: Klenerman, P, et al.
Published: (2015)

Cellular immunity and acute hepatitis C infection.
by: Fitzmaurice, K, et al.
Published: (2008)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
by: Niko Beerenwinkel, et al.
Published: (2013-01-01)

Correction: 24 Hours in the Life of HIV-1 in a T Cell Line.
by: Pejman Mohammadi, et al.
Published: (2015-06-01)

24 hours in the life of HIV-1 in a T cell line.
by: Pejman Mohammadi, et al.
Published: (2013-01-01)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
by: Hasse, B, et al.
Published: (2014)

Dominant influence of an HLA-B27 restricted virus-specific CD8+T cell response in viral clearance and viral adaptation in hepatitis C virus infection
by: Neumann-Haefelin, C, et al.
Published: (2005)

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
by: Fux, C, et al.
Published: (2007)

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
by: Neumann-Haefelin, C, et al.
Published: (2006)

Activity of ancestral restriction factors against ancient retroviruses
by: Ciuffi Angela, et al.
Published: (2009-09-01)